Compliant Analysis of Patient Samples and Data
Use of Patient Samples and Corresponding Clinical Data for Research and Development Studies And/or Population-based Analysis
Sequenom, Inc.
2,000 participants
Mar 17, 2018
OBSERVATIONAL
Conditions
Summary
Patients of scientific interest who have provided a commercial sample to LabCorp or one of its' affiliates will have their de-identified remnant samples and/or data used for research and development. Other commercial patients will be followed up on after informed consent is obtained.
Eligibility
Inclusion Criteria5
- Arm 1
- All samples and data are de-identified and HIPAA compliant
- Arm 2
- Subject is of scientific interest to the Sponsor or treating physician
- Subject provides written informed consent and has a clinical sample and/or supporting clinical data collected.
Exclusion Criteria4
- Arm 1
- Subject is from a US state or a country where local law restricts the use of de-identified data and/or remnants of specimens for research and/or development
- Arm 2
- Any medical or mental condition that would interfere with the subjects' ability to willingly give written informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Remnant samples and corresponding data from multiple diagnostic tests will be stored for future research and development.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04364503